Follicle Thought Special
An overview of treatments for pattern baldness and alopecia which will be in the clinical trial stage during 2023. Androgenetic Alopecia Trials Chong Kun Dang Pharmaceutical – We begin the list with a newcomer, previously unannounced. CKD-843 is a new injectable drug being trialed in “alopecia” by the Chong Kun Dang (CKD) Pharmaceutical company of Seoul,…
Read MoreIn this article we will cover the most prominent therapeutic candidates in the alopecia areata treatment industry in 2025. Alopecia Areata Pharmaceutical & Biotech Therapies In Development AnaptysBio – Rosnilimab or ANB030 is a Anti-PD-1 agonist. It is currently being evaluated in a 45 patient phase 2 clinical trial in moderate to severe alopecia areata.…
Read MoreUpdated October 2023 This post contains a list of the most viable and relevant hair regeneration treatments which are in development. They can be referred to as hair loss cures, baldness cures, hair growth treatments, hair loss treatments, or cures for androgenic alopecia. The treatments listed in this guide are ranked by a combination of…
Read More